• Exchange: FN Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

KAN:SS

5.1500 SEK 0.1000 1.90%

As of 12:00:00 ET on 12/23/2014.

Snapshot for Kancera AB (KAN)

Open: 5.2500 Day's Range: 5.0500 - 5.3000 Volume: 547,262
Previous Close: 5.2500 52wk Range: 1.3600 - 10.0500 1-Yr Rtn: +217.90%

Stock Chart for KAN

No chart data available.
  • KAN:SS 5.1500
  • 1D
  • 1M
  • 1Y
5.2500
Interactive KAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KAN

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -0.2200
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 507.52
Shares Outstanding (M) 98.55
30 Day Average Volume 740,672
Price/Book (mrq) 8.7665
Price/Sale (ttm) 95.7849
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KAN

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KAN

Kancera AB is a biotechnology company. The Company focuses on the development and sale of drug candidates that have the potential to cure or slow down the development of cancer.

Erik NerpinNon-Executive ChairmanThomas OlinChief Executive Officer
Martin NorinCSOLars Ahrlund-RichterCSO
More Company Profile & Key Executives for KAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil